NDC 55700-867 Belbuca
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 55700 - Quality Care Products, Llc
- 55700-867 - Belbuca
Product Characteristics
Product Packages
NDC Code 55700-867-60
Package Description: 60 POUCH in 1 BOX / 1 FILM, SOLUBLE in 1 POUCH
Product Details
What is NDC 55700-867?
What are the uses for Belbuca?
Which are Belbuca UNII Codes?
The UNII codes for the active ingredients in this product are:
- BUPRENORPHINE HYDROCHLORIDE (UNII: 56W8MW3EN1)
- BUPRENORPHINE (UNII: 40D3SCR4GZ) (Active Moiety)
Which are Belbuca Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYETHYL CELLULOSE (280 MPA.S AT 5%) (UNII: B24JYI97VR)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- PEPPERMINT OIL (UNII: AV092KU4JH)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
- SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- POLYCARBOPHIL (UNII: W25LM17A4W)
- HYDROXYPROPYL CELLULOSE (90000 WAMW) (UNII: UKE75GEA7F)
- CARBOXYMETHYLCELLULOSE SODIUM (0.7 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 38 MPA.S AT 2%) (UNII: YGX74DKE74)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
What is the NDC to RxNorm Crosswalk for Belbuca?
- RxCUI: 1716069 - buprenorphine HCl 450 MCG Buccal Film
- RxCUI: 1716069 - buprenorphine 0.45 MG Buccal Film
- RxCUI: 1716071 - Belbuca 450 MCG Buccal Film
- RxCUI: 1716071 - buprenorphine 0.45 MG Buccal Film [Belbuca]
- RxCUI: 1716071 - Belbuca 0.45 MG (as buprenorphine HCl) Buccal Film
* Please review the disclaimer below.
Patient Education
Buprenorphine Buccal (chronic pain)
Buprenorphine (Belbuca) is used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. Buprenorphine (Belbuca) should not be used to treat pain that can be controlled by medication that is taken as needed. Buprenorphine (Belbuca) in a class of medications called opiate partial agonists. It works by changing the way the brain and nervous system respond to pain.
[Learn More]
Buprenorphine Sublingual and Buccal (opioid dependence)
Buprenorphine and the combination of buprenorphine and naloxone are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medications called opioid partial agonist-antagonists and naloxone is in a class of medications called opioid antagonists. Buprenorphine alone and the combination of buprenorphine and naloxone work to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".